Tablets of Abbott Laboratories' cholesterol drug TriCor. Photographer: JB Reed/Bloomberg
Tablets of Abbott Laboratories' cholesterol drug TriCor. Photographer: JB Reed/Bloomberg
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=968590970&utmp=%2Fphoto%2F2011-10-19%2Fabbott-to-separate-into-two-companies-focusing-on-drug-areas&utmhn=10.248.67.17&utmac=UA-11413116-12&utmhid=464507285)